Universe Pharmaceuticals (UPC) Enterprise Value (2020 - 2024)
Historic Enterprise Value for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to -$29.5 billion.
- Universe Pharmaceuticals' Enterprise Value rose 446.27% to -$29.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.5 billion, marking a year-over-year increase of 446.27%. This contributed to the annual value of -$29.5 billion for FY2025, which is 34270.09% down from last year.
- Latest data reveals that Universe Pharmaceuticals reported Enterprise Value of -$29.5 billion as of Q3 2025, which was up 446.27% from -$30.9 billion recorded in Q3 2024.
- Over the past 5 years, Universe Pharmaceuticals' Enterprise Value peaked at -$11.4 million during Q1 2024, and registered a low of -$30.9 billion during Q3 2024.
- Over the past 5 years, Universe Pharmaceuticals' median Enterprise Value value was -$2.7 billion (recorded in 2022), while the average stood at -$8.9 billion.
- In the last 5 years, Universe Pharmaceuticals' Enterprise Value crashed by 2615591.52% in 2022 and then soared by 4013.99% in 2024.
- Quarter analysis of 5 years shows Universe Pharmaceuticals' Enterprise Value stood at -$21.8 million in 2021, then plummeted by 26155.92% to -$5.7 billion in 2022, then increased by 7.65% to -$5.3 billion in 2023, then tumbled by 484.03% to -$30.9 billion in 2024, then grew by 4.46% to -$29.5 billion in 2025.
- Its last three reported values are -$29.5 billion in Q3 2025, -$30.9 billion for Q3 2024, and -$11.4 million during Q1 2024.